Al-Sawaf O, Lilienweiss E, Bahlo J, et al. High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia. Blood. 2020;135(11):866-870.

doi:10.1182/blood.2022015745

Al-Sawaf O, Lilienweiss E, Bahlo J, et al. High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia. Blood. 2020;135(11):866-870.

Blood (2022) 139 (25): 3669.

https://doi.org/10.1182/blood.2022015745

In “Acknowledgments” on page 869, an acknowledgment of support from the Deutsche José Carreras Leukämie-Stiftung (grant 23 R/2017) was omitted. The error has been corrected in the online version of the article.

2022

Al-Sawaf O, Lilienweiss E, Bahlo J, et al. High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia. Blood. 2020;135(11):866-870.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology